Fibromyalgia: Present to future

Current Pain and Headache Reports

Volumn 8, Issue 5, 2004, Pages 379-384

  Bennett, Robert ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CATECHOL METHYLTRANSFERASE; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SUBSTANCE P; SYNAPTOPHYSIN;

CANCER; CELL ACTIVATION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FIBROMYALGIA; GENETIC POLYMORPHISM; GLIA CELL; HEALTH CARE ORGANIZATION; HEPATITIS C; HUMAN; HYPERALGESIA; INFLAMMATORY DISEASE; MENTAL STRESS; MOOD DISORDER; MUSCLE DISEASE; NOCICEPTIVE STIMULATION; PHYSICIAN; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PUBLICATION; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SENSITIZATION; UNITED STATES;

EID: 5144231445     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-996-0011-5     Document Type: Review

References (42)

1. Staud R: Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep 2002, 4:299-305.
2. Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990,33:160-172.
3. Smythe HA, Moldofsky H: Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1977, 28:928-931.
4. Neumann L, Buskila D: Epidemiology of fibromyalgia. Curr Pain Headache Rep 2003, 7:362-368.
5. Croft P, Burt J, Schollum J, et al i.]: More pain, more tender points: Is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis 1996, 55:482-485.
6. Desmeules JA, Cedraschi C, Rapiti E, et al.: Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003, 48:1420-1429.
7. Staud R: Fibromyalgia pain: Do we know the source? Curr Opin Rheumatol 2004, 16:157-163.
8. Wall PD, Woolf CJ: Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol 1984, 356:443-458.
9. Staud R, Cannon RC, Mauderli AP, et al.: Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003, 102:87-95.
10. Jubrias SA, Bennett RM, Klug GA: Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum 1994, 37:801-807.
11. Arendt-Nielsen L, Graven-Nielsen T: Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 2003, 7:355-361.
12. Sprott H, Salemi S, Gay RE, et al i.]: Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibers. Ann Rheum Dis 2004, 63:245-251.
13. Mense S: The pathogenesis of muscle pain. Curr Pain Headache Rep 2003, 7:419-425.
14. Watkins LR, Maier SF: Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci U S A 1999, 96:7710-7713.
15. Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for pathological pain. Trends Neurosci 2001, 24:450-455.
16. Obata K, Noguchi K: MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci 2004, 74:2643-2653.
17. Arici A: Local cytokines in endometrial tissue: the role of interleukin-8 in the pathogenesis of endometriosis. Ann N Y Acad Sci 2002, 955:101-109; discussion 118, 396-406.
18. Bajaj P, Bajaj P, Madsen H, Arendt-Nielsen L: Endometriosis is associated with central sensitization: a psychophysical controlled study. J Pain 2003, 4:372-380.
19. Trysberg E, Carlsten H, Tarkowski A: Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000, 9:498-503.
20. Uveges JM, Parker JC, Smarr KL: Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum 1990, 33:1279-1283.
21. Boscarino JA: Diseases among men 20 years after exposure to severe stress: implications for clinical research and medical care. Psychosom Med 1997, 59:605-614.
22. Amir M, Kaplan Z, Neumann L, et al.: Post-traumatic stress disorder, tenderness, and fibromyalgia. J Psychosom Res 1997, 42:607-613.
23. Cohen H, Neumann L, Haiman Y, et al.: Prevalence of posttraumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum 2002, 32:38-50.
24. Volpato S, Guralnik JM, Ferrucci L, et al.: Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001, 103:947-953.
25. Adler GK, Kinsley BT, Hurwitz S, et al.: Reduced hypothalamic pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999, 106: 534-543.
26. Bremner JD, Vythilingam M, Anderson G, et al.: Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol Psychiatry 2003, 54:710-718.
27. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al.: Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A 2003, 100: 9090-9095.
28. Capuron L, Hauser P, Hinze-Selch D, et al.: Treatment of cytokine-induced depression. Brain Behav Immun 2002, 16:575-580.
29. Altier N, Stewart J: The role of dopamine in the nucleus accumbens in analgesia. Life Sci 1999, 65:2269-2287.
30. Altier N, Stewart J: Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther 1998, 285:208-215.
31. Wood PB: Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med Hypotheses 2004, 62:420-424.
32. Ji RR: Mitogen-activated protein kinases as potential targets for pain killers. Curr Opin Investig Drugs 2004, 5:71-75.
33. Arnold LM, Hudson JI, Hess EV, et al.: Family study of fibromyalgia. Arthritis Rheum2004, 50:944-952.
34. Ehrlich GE: Pain is real; fibromyalgia isn't. J Rheumatol 2003, 30:1666-1667.
35. Owens MJ, Nemeroff CB: Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994, 40:288-295.
36. Cohen H, Buskila D, Neumann L, Ebstein RP: Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002, 46:845-847.
37. Offenbaecher M, Bondy B, de Jonge S, et al.: Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999, 42:2482-2488.
38. Gursoy S: Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin Rheumatol 2002, 21:194-197.
39. Arnold LM, Iyenger SK, Kahn MA, et al.: Genetic linkage of fibromyalgia to the serotonin receptor 2A region on chromosome 513 [Abstract 108]. Arthritis Rheum 2003,48(suppl).
40. Gursoy S, Erdal E, Herken H, et al.: Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int 2001, 21:58-61.
41. 158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
42. Gursoy S, Erdal E, Herken H, et al.: Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003, 23:104-107.